Internal Medicine, Hematology & Oncology · Framingham, MA
NPI
1568409936
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
571 Union Ave Ste 202
Framingham, MA, 01702
Phone (508) 665-6261
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
250,959 services
Medicare patients, 2024
742
Average age 77
Drug cost, 2024
$2.8M
968 prescriptions
Company payments, 2025
$1,556
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rasmia A Ahmed was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 70,890 times for 52 patients. In total Rasmia A Ahmed billed 250,959 services in 108 codes, and Medicare paid $2.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 70,890 | 52 | $0.28 | $20K |
| J0897 Injection, denosumab, 1 mg | Office | 19,200 | 154 | $20.41 | $392K |
| J1756 Injection, iron sucrose, 1 mg | Office | 13,800 | 13 | $0.18 | $2,475 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 11,180 | 27 | $6.08 | $68K |
| 85025 Blood Count | Office | 1,870 | 430 | $7.58 | $14K |
| 99214 Office E&M - Established | Office | 1,642 | 501 | $104.08 | $171K |
| 36415 Venipuncture Blood Collection | Office | 1,429 | 459 | $8.65 | $12K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,160 | 14 | $0.07 | $83.4 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,126 | 13 | $0.09 | $101 |
| 96372 Injection Administration | Office | 877 | 210 | $12.20 | $11K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 579 | 102 | $0.51 | $296 |
| 96375 Injection Administration | Office | 540 | 39 | $13.73 | $7,415 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 520 | 12 | $0.23 | $119 |
| 99213 Office E&M - Established | Office | 436 | 160 | $73.29 | $32K |
| 96365 Intravenous Infusion, Hydration | Office | 391 | 132 | $55.98 | $22K |
By year: 2022 $2.8M for 230,829 services; 2023 $3.0M for 215,739 services; 2024 $2.9M for 250,959 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,870 | 430 | $7.58 | $14K |
| 36415 Venipuncture Blood Collection | 1,429 | 459 | $8.65 | $12K |
| 80053 Clinical Chemistry | 369 | 65 | $10.19 | $3,759 |
Medicare prescription drug claims, 2024
In 2024, the drug Rasmia A Ahmed prescribed most often to Medicare patients was Eliquis (Apixaban), with 117 prescriptions and refills. In total Rasmia A Ahmed wrote 968 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 117 | 267 | 45 | $151K |
| Anastrozole Generic | 79 | 193 | 30 | $2,129 |
| Kyprolis Carfilzomib | 72 | 72 | Under 11 | $278K |
| Alendronate Sodium Generic | 68 | 180 | 29 | $623 |
| Prochlorperazine Maleate Generic | 27 | 27 | 23 | $390 |
| Xarelto Rivaroxaban | 24 | 66 | Under 11 | $34K |
| Levothyroxine Sodium Generic | 23 | 36 | Under 11 | $243 |
| Trazodone Hcl Generic | 22 | 44 | Under 11 | $75.73 |
| Acyclovir Generic | 22 | 38 | Under 11 | $336 |
| Gabapentin Generic | 20 | 38 | Under 11 | $130 |
| Hydroxyurea Generic | 20 | 48 | 11 | $746 |
| Fentanyl Generic | 19 | 19 | Under 11 | $1,782 |
| Brukinsa Zanubrutinib | 19 | 19 | Under 11 | $256K |
| Oxycodone Hcl Generic | 18 | 18 | Under 11 | $153 |
| Dexamethasone Generic | 18 | 22 | Under 11 | $288 |
Brand drugs: 394 claims; generic drugs: 574 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rasmia A Ahmed $1,556 ($1,556 in general payments such as food, travel and fees) from 34 companies. The largest payer was Pfizer Inc. with $133.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 6 | $133 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $122 |
| Janssen Biotech, Inc. JNJ | 4 | $113 |
| Genzyme Corporation SNY | 3 | $91 |
| Sobi, Inc SOBI.ST | 2 | $86.75 |
| Merck Sharp & Dohme LLC MRK | 3 | $84.57 |
| Eisai Inc. 4523.T | 3 | $80.18 |
| Genentech USA, Inc. ROG.SW | 2 | $72.9 |
| Celgene Corporation BMY | 2 | $65.77 |
| Agios Pharmaceuticals, Inc. AGIO | 2 | $59.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.